Antibodies, B Cell Development, and Effector Functions

Comprehensive vocabulary flashcards covering immunoglobulin structure, genetic recombination, B-cell development in the bone marrow, secondary lymphoid activation, germinal centers, and antibody effector mechanisms.

Immunoglobulin (Ig) Structure

A "Y"-shaped glycoprotein with a total molecular weight of approximately $150\text{ kD}$, composed of two identical heavy chains ($\sim 50\text{ kD}$ each) and two identical light chains ($\sim 25\text{ kD}$ each) held together by disulfide bonds.

Fab Fragment

The "fragment antigen-binding" arm produced by protease cleavage of an antibody; it contains an entire light chain paired with the variable and first constant domain ($V_H$ and $C_H1$) of a heavy chain, retaining the antigen-binding site.

Fc Fragment

The "fragment crystallizable" stem of an antibody produced by protease cleavage; it consists exclusively of paired constant heavy-chain regions ($C_H2$ and $C_H3$) and mediates downstream effector functions by interacting with complement and Fc receptors.

Variable (V) Region

The amino-terminal region of both heavy and light chains that exhibits extreme sequence variation between antibodies produced by different B cells, forming the antigen-binding site.

Constant (C) Region

The carboxyl-terminal region of both heavy and light chains that has limited amino acid variation within a species, dictating the antibody isotype class and recruitment of specific immune effector mechanisms.

Linear Epitope

An antigenic determinant formed by a continuous, sequential run of amino acid residues in the primary sequence of a protein antigen, capable of binding antibodies even when the protein is unfolded or denatured.

Discontinuous Epitope

A conformational antigenic determinant composed of non-sequential amino acids that are brought together in physical space only by the three-dimensional tertiary folding of the native protein.

Germline Configuration

The inherited, fragmented state of immunoglobulin gene segments ($V$, $D$, and $J$) spread sequentially along chromosomes in egg and sperm DNA, which must undergo rearrangement in developing B cells to form a functional gene.

Immunoglobulin Gene Chromosomal Locations

In humans, heavy-chain genes are located on chromosome $14$, kappa ($\kappa$) light-chain genes are on chromosome $2$, and lambda ($\lambda$) light-chain genes are on chromosome $22$.

Somatic Recombination (V(D)J Recombination)

The irreversible cutting and splicing of DNA during B cell development in the bone marrow, involving one recombination event for the light chain ($V$ to $J$) and two events for the heavy chain ($D$ to $J$, followed by $V$ to $DJ$).

Combinatorial Diversity of Immunoglobulin Heavy and Light Chains

Human heavy chains generate $5,520$ combinations ($40\text{ V} \times 23\text{ D} \times 6\text{ J}$), $\kappa$ chains generate $175$ combinations ($35\text{ V} \times 5\text{ J}$), and $\lambda$ chains generate $120$ combinations ($30\text{ V} \times 4\text{ J}$), yielding $1,628,400$ total potential heavy/light chain pairings.

12/23 Rule

The recombination rule stating that a recombination signal sequence (RSS) with a $12\text{ base pair}$ (one-turn) spacer can only join to an RSS with a $23\text{ base pair}$ (two-turn) spacer, ensuring that $V_H$ and $J_H$ cannot directly join without an intervening $D_H$ segment.

RAG Complex (RAG-1 and RAG-2)

The lymphocyte-specific endonuclease complex that binds recombination signal sequences (RSSs), cleaves DNA to generate DNA hairpins, and initiates somatic V(D)J recombination in developing B cells.

Junctional Diversity

The extensive nucleotide variability introduced at the junctions between recombined gene segments, generated by RAG-mediated single-strand nicking that produces palindromic P-nucleotides and subsequent addition of random N-nucleotides.

Terminal Deoxynucleotidyl Transferase (TdT)

The enzyme that adds non-templated, random N-nucleotides to the single-stranded DNA ends after hairpin opening during somatic recombination, dramatically diversifying coding joints.

Allelic Exclusion

The phenomenon whereby a diploid B cell expresses heavy- and light-chain genes from only one parental chromosome; successful rearrangement of one allele triggers feedback that shuts down rearrangement of the homologous allele.

Early Pro-B Cell

The earliest recognizable B-cell developmental stage in the bone marrow, characterized by the somatic joining of a $D$ gene segment to a $J$ gene segment on both heavy-chain alleles.

Late Pro-B Cell

The B-cell developmental stage where a $V$ gene segment rearranges to join the pre-formed $DJ$ segment on the first heavy-chain chromosome (and if nonproductive, on the second chromosome).

Pre-B-Cell Receptor Checkpoint

A critical quality-control checkpoint in large pre-B cells where the newly formed $\mu$ heavy chain pairs with surrogate light chain proteins (VpreB and $\lambda 5$); failure to assemble this functional receptor results in apoptosis, eliminating approximately $50\%$ of cells.

Small Pre-B Cell

The developmental stage following the first checkpoint where light-chain gene rearrangement begins, attempting $\kappa$ gene rearrangement first (on both chromosomes) before attempting $\lambda$ gene rearrangement.

Immature B Cell

A B cell that has successfully completed both heavy- and light-chain gene rearrangements and expresses complete, functional IgM molecules on its cell surface, having not yet encountered foreign antigen.

Hybridoma

An immortalized cell line produced by fusing an antigen-specific B cell from an immunized mouse with a cancerous myeloma cell, grown in selective drug-containing medium to manufacture identical monoclonal antibodies indefinitely.

Monoclonal Antibody Naming Conventions

Therapeutic monoclonal antibodies are classified by their origin using specific suffixes: "-omab" for fully mouse, "-ximab" for chimeric, "-zumab" for humanized, and "-umab" for fully human antibodies.

Alternative RNA Splicing (Immunoglobulin)

The post-transcriptional mechanism used by B cells to regulate whether IgM is membrane-bound or secreted by selecting between alternative polyadenylation sites ($\text{pA}_{\mu m}$ vs. $\text{pA}_{\mu s}$) without altering DNA sequence.

Somatic Hypermutation

The introduction of single-nucleotide substitutions into the rearranged $V$ domains of immunoglobulin heavy and light chains in activated B cells, concentrated in hypervariable regions (CDR1, CDR2, and CDR3).

Activation-Induced Cytidine Deaminase (AID)

The B-cell-specific enzyme activated upon antigen exposure that initiates somatic hypermutation and class switching by deaminating cytidine to uracil in single-stranded DNA.

Affinity Maturation

The survival-of-the-fittest process during an immune response where somatic hypermutation generates B-cell clones with differing affinities, and those with higher affinity for antigen outcompete others to proliferate and dominate antibody production.

Class Switching (Isotype Switching)

A DNA recombination event driven by AID targeting repetitive switch ($S$) regions upstream of heavy-chain constant genes, replacing the $C_\mu$ domain with a downstream constant region (such as $C_\gamma$, $C_\alpha$, or $C_\epsilon$) while preserving antigen specificity.

Pentameric IgM

The secreted form of IgM consisting of five monomeric units joined by a single $J$ chain; it possesses $10$ antigen-binding sites, providing high overall avidity and powerful complement activation despite low individual intrinsic affinity.

Secondary Lymphoid Organ Architecture (Lymph Node)

The anatomical filter where adaptive immunity is initiated; naive B cells occupy primary lymphoid follicles while T cells localize to the T-cell area, with fluid entering through afferent lymphatic vessels and exiting via efferent vessels.

B-Cell Receptor (BCR) Complex Signaling

The activation cascade where antigen-mediated cross-linking of surface BCRs clusters receptor-associated kinases (Blk, Fyn, or Lyn) to phosphorylate ITAMs on $\text{Ig}\alpha$ and $\text{Ig}\beta$, recruiting and activating Syk kinase to alter nuclear gene expression.

Follicular Dendritic Cells (FDCs)

Non-lymphoid stromal cells residing in primary follicles that use complement receptor 2 (CR2/CD21) to trap and display intact, native antigens on their surfaces for screening by naive and memory B cells.

Cognate Interaction (Cognate Pair)

The cell-cell conjugate formed at the boundary of follicle and T-cell zones when an antigen-activated B cell presents specific peptide on MHC class II to an activated follicular helper T ($T_{FH}$) cell, engaging CD40-CD40L and directed cytokine secretion.

Primary Focus of B Cell Expansion

The initial proliferative cluster of antigen-activated B-T cognate pairs located in the medullary cords of the lymph node, producing early plasma cells that secrete low-affinity IgM without undergoing somatic hypermutation or class switching.

Germinal Center

The specialized, dynamic structure formed in a primary follicle (the secondary focus) where proliferating B cells undergo somatic hypermutation, affinity maturation, and isotype switching under the influence of $T_{FH}$ cells and FDCs.

Centrocyte Selection

The competitive testing of non-dividing germinal center B cells (centrocytes) for binding to native antigen on FDCs; centrocytes whose mutated BCRs bind antigen cross-link, present it to $T_{FH}$ cells, and receive survival signals ($\text{Bcl-X}_L$), while low-affinity cells undergo apoptosis.

Memory B Cells

Long-lived, quiescent B cells induced from high-affinity centrocytes primarily by $T_{FH}$-derived IL-4; they express high-affinity, isotype-switched surface receptors and reside in tissues to mount rapid secondary responses upon encountering the same antigen.

FcRn (Neonatal Fc Receptor)

An Fc receptor on endothelial cells that binds the Fc portion of pinocytosed IgG within acidic endosomes ($\text{pH} < 6.5$), diverting it from lysosomal degradation and releasing it at neutral/basic extracellular pH into tissues.

Poly-Ig Receptor (pIgR)

A polymeric receptor on the basolateral surface of mucosal epithelial cells that binds the $J$ chain of dimeric IgA (and pentameric IgM) to mediate receptor-mediated transcytosis to the apical luminal surface.

Secretory Piece

The cleaved extracellular fragment of the poly-Ig receptor that remains bound to dimeric IgA upon release into the mucosal lumen, anchoring secretory IgA to mucin proteins to protect against mucosal colonization.

FcεRI

The high-affinity receptor for the Fc region of IgE found constitutively on mast cells and basophils (and inducible on eosinophils); cross-linking of bound IgE by multivalent antigen triggers explosive degranulation of histamine and other inflammatory mediators.

Passive Immunity

Protection conferred by the transfer of pre-formed antibodies from another individual or source (e.g., maternal IgG crossing the placenta, breast milk IgA, antivenoms, or antitoxins), providing immediate protection without activating host B cells or creating immunological memory.

Transient Low IgG Levels (Infant Window of Susceptibility)

The period between approximately $3$ and $9\text{ months}$ after birth when maternal IgG transferred across the placenta has degraded, but the infant's newly synthesized IgG has not yet reached protective levels.

Neutralization

The binding of high-affinity antibodies (predominantly IgG and dimeric IgA) to surface proteins of pathogens or toxins, directly blocking their adherence to host cell receptors and preventing entry or infection.

Agglutination

The clumping of soluble multivalent antigens or whole cells (such as red blood cells during ABO-mismatched blood transfusion) caused by the cross-linking of surface antigens by multivalent antibodies like pentameric IgM.

Immune Complex Clearance Pathway

The physiological mechanism where circulating antigen:antibody complexes activate complement, become covalently coated with $C3b$, bind complement receptor 1 (CR1) on erythrocytes, and are ferried to the liver and spleen where macrophages detach and degrade them.

FcγRI (CD64)

The high-affinity Fc receptor expressed on myeloid cells (monocytes, macrophages, and dendritic cells) that binds the lower hinge and $C_H2$ domain of monomeric IgG1 and IgG3, mediating opsonization and phagocytosis.

Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC)

The process by which natural killer (NK) cells express $\text{Fc}\gamma\text{RIII}$ (CD16) to bind the Fc region of IgG antibodies coating a target cell (such as anti-CD20 rituximab on B lymphoma cells), triggering directed degranulation and apoptosis of the target cell.

Bruton's Tyrosine Kinase (BTK) Deficiency

A genetic signaling defect in B-cell survival and maturation that prevents pro-B cells from progressing beyond the pre-B stage, leading to a complete lack of circulating B cells and immunoglobulins (X-linked agammaglobulinemia) while leaving T cells unaffected.